Diagnostic Cytopathology

Cover image for Vol. 42 Issue 5

Edited By: Carlos W.M. Bedrossian, MD

Impact Factor: 1.487

ISI Journal Citation Reports © Ranking: 2012: 17/32 (Medical Laboratory Technology); 55/77 (Pathology)

Online ISSN: 1097-0339


Author Guidelines


Editorial Office


Editor-in-Chief: Dr. Carlos Bedrossian
Managing Editor: Elizabeth Brenner
Production Editor: Mark Eidam

Questions about submissions or queries on the status of a manuscript can be submitted to the Editorial Office at dcjrnl@wiley.com.

Questions about accepted papers, page proofs, publication dates, copies of published articles, and color figure charges can be submitted to the Production Office at jrnlproddc@cadmus.com.

Author Services
Please visit Wiley's Author Services - an enhanced suite of online tools for Wiley journal authors, featuring pre-submission article resources, Copyright License filing, post-acceptance article tracking, e-mail publication alerts and more.

NIH Public Access Mandate
For those interested in the Wiley-Blackwell policy on the NIH Public Access Mandate, please visit our policy statement

Open Access
For information on Wiley's Open Access publishing options for authors, please click here.

Journal Overview
Diagnostic Cytopathology is a monthly publication presenting the latest information on the practical applications of clinical cytology in determining the etiology, diagnosis, prognosis and therapeutic options of benign and malignant disease. The journal welcomes articles based on the study of cyto-histological samples obtained in a non-invasive fashion and examined by routine and ancillary methods. Committed to bridging the gap between cytopathology and surgical pathology, Diagnostic Cytopathology stresses the value of clinical-pathological correlations, as well as the correlation between cytological and histological findings, as the gold standard for the accuracy and reliability of cytological diagnoses. Whereas the early diagnosis of cancer remains at the core of our publishing philosophy, topics of interest include all subjects that impact the practice of cytopathology and its scientific basis.

Symposium Issues. Diagnostic Cytopathology publishes both print and on-line-only special issues dedicated to a single topic or organ system. These themed issues are usually by invitation to a guest editor, but the journal will consider proposals from authors and organizations willing to cover the expenses of publishing a portion of or a complete special issue. Proposals must be submitted via email to the editorial office and include the topic, the number of articles, potential authors, length of the papers, number of illustrations, and other pertinent details, including sponsorship information, source of funding, and disclosures. Sponsorship may be in the form of advertising pages for products related to the practice of cytopathology, or funding to cover the cost of publication online or in print. Proceedings of meetings will not be considered for publication as a special issue. Topics must first be reviewed by the editorial board and all articles will be peer-reviewed prior to their publication. Ample amount of time should be allotted to the production time of these special issues.


Types of Article Published in Diagnostic Cytopathology:

Original Article. Studies of a large series of cases (usually 12 or more) obtained as fine needle aspiration and core biopsies, non-gynecological specimens and gynecological samples, including liquid-based preparations. Focus: cyto-histological correlation; new information derived from assessment of sensitivity, specificity and accuracy of a diagnostic modality; impact of newer procedures for collection of clinical samples; cost-effectiveness of different approaches for the diagnosis of the same entity; applications of newly developed immuno-histochemical markers to elucidate the phenotype of cell populations; newer applications of existing methodologies, including automation, morphometry, electron microscopy, flow cytometry, image analysis, cytogenetics, in-situ hybridization and other ancillary techniques applicable to small cyto-histological samples; and other topics based on original observations, new insights and novel utilization of established technologies. Restrictions: None

Brief Report. Report of a single case or a small series with unique content and exceptional clarity. Reports should be succinct with a single well-defined message. Focus: rare conditions, unique findings, overlapping features, uncommon presentations, unexpected outcomes, confounding factors and other unusual observations. Note: Authors may be asked to revise and re-submit a Brief Report in the Letter to the Editor or Images in Cytology format, in order to maximize the value of their reported experience. Restrictions: 1200 words of body text for a single case, 1500 words of body text for a small series; maximum 6 figures

Timely Review. Comprehensive review and/or critique of the literature paired with the authors’ experience of an organ system, clinical condition, or technology. Must be thorough and provide educational value and scientific insight. Restrictions: None

Images in Cytology. Rely on the visual singularity of their illustrations to call attention to a rare condition or provide exceptionally classical examples of a common entity. Succinct reviews of the literature add value. Authors should be concise in descriptions of cytological findings; the pictures tell the story and catch the attention of the reader. Restrictions: 1000 words of body text; maximum 6 figures

Molecular Cytopathology. Describe original observations based on translational research, molecular testing, and the identification of targets for novel forms of treatment. Restrictions: None

Letter to the Editor. Commentaries in response to a recently published article, or focused, timely communications of immediate interest to the readership. Letters may also describe a unique clinical observation in a shorter format than a brief report, or consist of opinions that benefit from a direct style and a shorter length than an Editorial. Restrictions: 1000 words of body text; maximum 3 figures and 1 table

Editorial. Recognized leaders in the field of cytopathology may offer their opinions regarding an article or a group of related papers appearing in the same issue of the journal. Editorials are usually by invitation of the Editor-in-Chief but may also include the unsolicited analysis of new trends in the practice of cytopathology or the author’s perspective on articles recently published in Diagnostic Cytopathology or in another journal. Restrictions: None

Book Review. Reviews of newly-published text-books, atlases and monographs dedicated to cytopathology and its related disciplines. Organ-specific books with emphasis on cyto-histological correlation and adjunctive technique as well as texts with advances in new technology are also welcome. Restrictions: 1000 words of body text

Special Contribution. Diagnostic Cytopathology will consider for publication special articles that highlight the solution of diagnostic dilemmas, the history of the field, geographic cytopathology, communications from professional organizations, and presentations of new regulations and special developments in practice. For more information on submitting a Special Contributions article, please query the editorial office.


Publication Ethics. Wiley-Blackwell is a member of the UK Committee on Publication Ethics. Authors must disclose funding sources and conflicts of interest (for more details, see "Title Page" under "Submissions" below. Authors must follow ethical guidelines in experiments and verify this in the Methods section of their work (for more details, see "Methods Section" under "Submissions" below). Original textual matter quoted from other authors must have formal citation and be appropriately attributed and referenced. Any statements that might be construed as defamatory must be avoided. The Editors reserve the right to reject a paper on ethical grounds. For more detailed ethical guidelines, please visit: http://www.wiley.com/bw/publicationethics/.



Author Guidelines


Submissions

All manuscripts should be submitted online using Manuscript Central. This site allows authors to upload their manuscript text, figures, and related files in appropriate formats. The system then generates a pdf for review. Please follow the instructions below to create your submission.


Manuscript Document Requirements
Manuscripts must be submitted in .doc or .rtf file format. All text must be double-spaced with a ragged right margin. All section headers and paragraphs should begin flush left with no indents. Please use one space between each paragraph and two spaces between sections of text.

Avoid using text boxes, linked text, hidden text, automatic numbering of references and lists, endnotes or footnotes, and all other forms of automatic formatting. Please do not place a hard return at the end of every line. These types of formatting are removed, and this removal can produce errors.

Detailed information on style and preparation of manuscripts is in Scientific Style and Format: The CBE Manual for Authors, Editors, and Publishers, 7th edition (2006, Council of Science Editors in cooperation with the Rockefeller University Press).

English Language. All manuscripts must be written in clear, correct English. Manuscripts not meeting the language requirement may be declined without peer review at the Editor’s discretion. Authors for whom English is a second language may choose to have their manuscript professionally edited before submission to improve the English. A list of independent suppliers of editing services can be found here. Japanese authors can also find a list of local English improvement services here. All services are paid for and arranged by the author, and use of one of these services does not guarantee acceptance or preference for publication.

Please be aware that the total file size of your submission cannot exceed 500,000 K.

Please arrange your text and other elements in the following order:


Title Page. The first page of the manuscript. Must include all of the following:
  • Title and short (running) title
  • Full names and affiliations for all authors, including the highest academic degree
  • Full postal address, telephone and fax number, and e-mail address for the corresponding author, to whom the proofs will be sent
  • Conflict of Interest statement
  • Disclosure of grants or other funding

Authors are expected to disclose, on the title page of their manuscripts, any commercial or other associations that might pose a conflict of interest in connection with the submitted article. All funding sources supporting the work, and institutional or corporate affiliations of the authors, should be acknowledged on the title page. These statements will be published in the journal.


Abstract and Keywords. The second page of the manuscript. Abstracts are required for all papers except Letters to the Editor and Images in Cytology. Brief Reports: single unstructured paragraph of 250 words or less that states the principal findings and conclusions. Original Articles: structured in four sections: Background, Methods, Results, Conclusion. Review and Technology articles: structured or unstructured as appropriate for the sections of the paper.

All articles must include 3 to 6 key words suitable for indexing.


Sections and Subheadings. The text should be organized, if possible, into the following sections: Abstract and keywords, Body of Article, Acknowledgments, References, Figure Legends.
Original Articles: the body text should have the following subheadings: Introduction, Materials and Methods, Results, Discussion.
Brief Reports: the body text should have the following subheadings: Introduction, Case Report(s), Discussion/Conclusion. Materials and Methods and Results/Findings may be included as necessary.
Images in Cytology, Advances in Technology, Timely Reviews, and Letters to the Editor should follow the structures of scientific writing with appropriate variations on standard section content as needed.


Methods Section. When reporting research on human subjects, the work must comply with the principles of the Declaration of Helsinki. Experiments using human tissue must be shown to comply with national and local ethical guidelines. Authors must confirm that an ethics committee granted apoproval of the study, and where appropriate, that all subjects gave informed consent.


References. In the text, cite references using sequential Arabic numerals in superscript. In the References section, articles should be numbered consecutively in the order in which they appear in the text. Only articles that have been published or are in press may be included in the Reference section. Authors are encouraged to rely upon citation of articles published in primary research journals. Citations like "personal communication" or "submitted" should not be listed in the references but may be inserted parenthetically into the text at the appropriate point. Authors must obtain a signed letter of permission from cited persons to use unpublished results or personal communications in the manuscript.

Notes: Use journal abbreviations as adopted by Index Medicus. Do not use any italics. For author names, do not use spaces or periods between initials. For an entire book, the total number of pages is given. For book chapters and journal articles, please give the complete page range of the chapter or article. For assistance, you may wish to consult the websites maintained by the National Library of Medicine (USA) at http://www.ncbi.nlm.nih.gov/entrez/query/static/citmatch.html or http://www.nlm.nih.gov/pubs/formats/internet.pdf.

Examples

Journal article:
Campbell JL, Nash HA. Volatile general anesthetics reveal a neurobiological role for the white and brown genes of Drosophila melanogaster. J Neurobiol 2001;49:339-349.

Entire Book:
Voet D, Voet JG. Biochemistry. New York: John Wiley & Sons; 1990. 1223 p.

Chapter in a book:
Gilmore ML, Rouse ST, Heilman CJ, Nash NR, Levey AI. Receptor fusion proteins and analysis. In: Ariano MA, editor. Receptor localization. New York: Wiley-Liss; 1998. p 75-90.

You may wish to use the EndNote system to assist you in formatting your references. More information, including Diagnostic Cytopathology’s reference style, can be found at authorservices.wiley.com/jendnotes/.


Figure Legends. Include as a list following the References section. Legends should provide sufficient information to allow the reader comprehension without reference to the text.


Tables. Submit separately from the main manuscript document, created in a text file (.doc or .rtf). Each table must start on a new page. All tables should be double-spaced. Title all tables at the top, and number them in order of their citation in the text. Any notes should appear at the bottom of the table.


Figures (Illustrations). Submit separately from the manuscript text document. Each Figure must be an individual file upload. Do not embed legends within figure files. Illustrations should be referred to in the text as “Figs” and be given Arabic numbers.

The journal can accept JPG, TIFF and EPS image file formats ONLY. Figures submitted as Bitmap, Excel, PowerPoint, or Word document files will be returned to the author for re-submission. Color images should be saved in RGB color scheme. Photomicrographs and photographs must have a resolution of 300 dpi. Line artwork (e.g., vector graphics) must have a resolution of 600 dpi.

Photomicrographs should state the original magnification. Lines should be of sufficient thickness to stand reduction (no less than 4 mm wide for a 50% reduction), and letters should be a minimum of 9 pt Arial or an equivalent size. More detailed information on the preparation and submission of electronic artwork can be found here and here. To ensure that your digital graphics are suitable for print purposes, please go to RapidInspector™ at http://rapidinspector.cadmus.com/zwi/index.jsp. This free, stand-alone software application will help you to inspect and verify illustrations right on your computer.

Consent for Patient Photographs: Photographs with identifiable patients must include a consent form. See the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (www.icmje.org; section II.E.1). Please include completed and signed consent forms at time of manuscript submission.

Previously Published Illustrations and Tables: If an author wishes to include Illustrations and Tables that have been previously published, they must cite the previous publication and secure permission from the copyright holder. Further information and a template letter for securing permissions can be found here: http://authorservices.wiley.com/permission.asp. Please include completed and signed permissions forms for re-used illustrations and tables at time of manuscript submission.

Fee for Print Color Figures. For all accepted manuscripts, there will be a charge to authors for color pages used in the print version of the journal. Wiley-Blackwell requires you to complete and return a color work agreement form before your paper can be published. This form will be sent to you upon acceptance of your paper. There are no charges to the author when the illustration appears in black and white in the printed version of the journal. All figures submitted in color will appear in color in the online version of the journal at no cost to the author. We recommend the use of symbols, rather than color, for graphs and charts. If you do not want to pay for print color, please be sure to use illustrations that will reproduce well in grayscale for the print version of your article.


Supplemental Material (for online publication only). Submit with the manuscript for peer-review and approval by the Editors. Reference supplemental materials within the text of the manuscript so that readers will be aware of its presence. Supplemental material can include figures, tables, movies, and animations. There are no restrictions on file types of the data, but please keep in mind that the more universal the file type, the more accessible to the community. We recommend that you submit supplemental figures in either jpg, tif or eps format, and movies in mov, wmv, mpg, or avi format. Online-only Supplemental Material will be published as submitted. It will not be copyedited or formatted by the publisher in any way. The accuracy and presentation of Supplemental Material is the sole responsibility of the authors.


Copyright License.
Accepted articles cannot be published until the publisher has received the appropriate signed license agreement. If your paper is accepted, the author identified as the formal corresponding author will receive an email prompting them to log into Wiley's Author Services, where via the Wiley Author Licensing Service (WALS) they will be able to complete the license agreement on behalf of all authors on the paper.

For authors signing the standard copyright transfer agreement
If the OnlineOpen option is not selected the corresponding author will be presented with the standard copyright transfer agreement (CTA) to sign. The terms and conditions of the CTA can be previewed in the samples associated with the Copyright FAQs below:
CTA Terms and Conditions http://authorservices.wiley.com/bauthor/faqs_copyright.asp

For authors choosing OnlineOpen
If the OnlineOpen option is selected the corresponding author will have a choice of the following Creative Commons License Open Access Agreements (OAA):
Creative Commons Attribution License OAA
Creative Commons Attribution Non-Commercial License OAA
Creative Commons Attribution Non-Commercial -NoDerivs License OAA
To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley Author Services http://authorservices.wiley.com/bauthor/faqs_copyright.asp and visit http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html.

If you select the OnlineOpen option and your research is funded by The Wellcome Trust and members of the Research Councils UK (RCUK) you will be given the opportunity to publish your article under a CC-BY license supporting you in complying with Wellcome Trust and Research Councils UK requirements. For more information on this policy and the Journal’s compliant self-archiving policy please visit: http://www.wiley.com/go/funderstatement.


Manuscript Checklist

  • Manuscript document (title page, complete manuscript text, references, figure legends)
  • Tables (separate text document; each table on a new page)
  • Figures(individual JPG, TIF, or EPS files)
  • As applicable: Supplemental Material, consent forms, permissions forms

Revisions. When submitting a revision, please mark the manuscript to show the changes made (highlighting, colored text, or “track changes” are acceptable methods). Also include a detailed “Response to Review” in which the authors respond to reviewer and editor comments point-by-point, so the revision can be thoroughly understood and evaluated.


Proofs. When an article has been accepted, the publisher will send the corresponding author a link to a website where proofs are available for final review before publication. A working e-mail address must therefore be provided for the corresponding author. In addition, please provide a secondary email address in case we have trouble reaching you at the first email address. Instructions will be sent with the proof. Hard copy proofs will be posted if no e-mail address is available. Excessive changes made by the author in the proofs, excluding typesetting errors, will be charged separately.

Policy on Review of Page Proofs: Manuscripts for Diagnostic Cytopthology are copyedited by a professional copyeditor hired by the publisher. The Editor will not check the typeset proofs of accepted manuscripts for errors, thus it is the responsibility of the primary author of each paper to review page proofs carefully for spelling and grammar, accuracy of citations and formulas, etc., and to check for omissions in the text. It is imperative that the author do a prompt, thorough job of reviewing the returned proofs. Page proofs must be returned to the publisher within 48 hours of receipt. An order form for offprints will be available with proofs.



??? Editorial Questions ???

Elizabeth Brenner
E-mail: dcjrnl@wiley.com



??? Production Questions ???

Production Editor
E-mail: jrnlproddc@cadmus.com

SEARCH

SEARCH BY CITATION